Home > Insider Trading > Filing (0000049071-12-000067)

Filing Details

Accession Number:: 0000049071-12-000067
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-04-03 15:54:01
Reporting Period:: 2012-03-30

Filing Date:: 2012-04-03
Accepted Time:: 2012-04-03 14:54:01
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
49071	Humana Inc	HUM	Hospital & Medical Service Plans (6324)	610647538

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1018658	E James Murray	Humana Inc. 500 West Main Street Louisville KY 40202	Evp & Coo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Humana Common	Acquisiton	2012-03-30	67,042	$62.10	177,467	No	4	M	Direct
Humana Common	Acquisiton	2012-03-30	32,439	$69.48	209,906	No	4	M	Direct
Humana Common	Acquisiton	2012-03-30	33,327	$41.83	243,233	No	4	M	Direct
Humana Common	Acquisiton	2012-03-30	19,042	$46.40	262,275	No	4	M	Direct
Humana Common	Acquisiton	2012-03-30	13,069	$61.18	275,344	No	4	M	Direct
Humana Common	Disposition	2012-03-30	102,918	$92.25	172,426	No	4	F	Direct
Humana Common	Disposition	2012-03-30	26,372	$92.25	146,054	No	4	F	Direct
Humana Common	Disposition	2012-03-30	5,000	$92.80	141,054	No	4	S	Direct
Humana Common	Disposition	2012-03-30	32,000	$92.91	109,054	No	4	S	Direct
Humana Common	Disposition	2012-03-30	1,000	$92.86	108,054	No	4	S	Direct
Humana Common	Disposition	2012-03-30	269	$92.25	107,785	No	4	G	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	F	Direct
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	G	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Humana Common	Options	Disposition	2012-03-30	67,042	$62.10	67,042	$62.10
Humana Common	Options	Disposition	2012-03-30	32,439	$69.48	32,439	$69.48
Humana Common	Options	Disposition	2012-03-30	33,327	$41.83	33,327	$41.83
Humana Common	Options	Disposition	2012-03-30	19,042	$46.40	19,042	$46.40
Humana Common	Options	Disposition	2012-03-30	13,069	$61.18	13,069	$61.18
Humana Common	Phantom Stock Units	Acquisiton	2012-03-30	78	$89.02	78	$0.00

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2014-02-22	No	4	M	Direct
38,234	2015-02-21	No	4	M	Direct
0	2016-02-19	No	4	M	Direct
19,042	2017-02-18	No	4	M	Direct
26,140	2018-02-17	No	4	M	Direct
29,475		No	4	J	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Humana Common	3,983	Indirect	See Footnote
Humana Common	1,356	Indirect	See Footnote
Humana Common	25,072	Indirect	See Footnote

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Humana Common	Options	$88.65	2019-02-23	48,747	48,747	Direct
Humana Common	Restricted Stock Units	$0.00		8,867	8,867	Direct
Humana Common	Restricted Stock Units	$0.00		28,668	28,668	Direct
Humana Common	Restricted Stock Units	$0.00		9,476	9,476	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2019-02-23	48,747	48,747	Direct
	8,867	8,867	Direct
	28,668	28,668	Direct
	9,476	9,476	Direct

Footnotes

Shares held by reporting person's spouse.
Shares held in The Murray Family trust.
Stock units held for the benefit of reporting person as of March 30, 2012 under the Humana Retirement & Savings Plan, including a routine disposition of shares to fund an administrative fee assessment under a Tax-Conditioned Plan. All transactions are exempt under Rule 16b-3(c).
Right to buy pursuant to Company's 2003 Stock Incentive Plan.
Incentive and Non-Qualified stock options granted to reporting person on 2/22/07, NQ options vesting in three increments from 2/22/08 to 2/22/10, and ISO's vesting on 2/22/10.
Incentive and Non-Qualified stock options granted to reporting person on 2/21/08, NQ options vesting in three increments from 2/21/09 to 2/21/11, and ISO's vesting on 2/21/11.
Reporting person was granted the maximum number of Incentive stock options allowed and remaining options were granted as Non-Qualified stock options. The option grant vests in three increments from 2/19/10 to 2/19/12.
Reporting person was granted the maximum number of Incentive stock options allowed and remaining options were granted as Non-Qualified stock options. The option grant vests in three increments from 2/18/11 to 2/18/13.
Reporting person was granted the maximum number of Incentive stock options allowed and remaining options were granted as Non-Qualified stock options. The option grant vests in three increments from 2/17/12 to 2/17/14.
Reporting person was granted the maximum number of Incentive stock options allowed and remaining options were granted as Non-Qualified stock options. The option grant vests in three increments from 2/23/13 to 2/23/15.
Right to receive one share per restricted stock unit pursuant to the Company's 2003 Stock Incentive Plan.
Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).
Restricted stock units granted to reporting person on 2/17/11, 100% of the award is vesting on 2/17/14.
Restricted stock units granted to reporting person on 11/7/11, 100% of the award is vesting on 11/7/13.
Restricted stock units granted to reporting person on 2/23/12, 100% of the award is vesting on 2/23/15.
Phantom Stock Units held for the benefit of reporting person as of March 30, 2012 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Excess Plan. 78 shares were acquired for a quarterly allocation of dividends under the Plan using the closing price of the dividend payable date on January 31, 2012. (The number of units reflect normal fluctuation due to changes in the stock price)
This price represents the weighted average sales price for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $92.80 to $92.81. Upon request by the SEC staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares and prices at which transactions were effected.
This price represents the weighted average sales price for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $92.515 to $93.01. Upon request by the SEC staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares and prices at which transactions were effected.
This price represents the weighted average sales price for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $92.851 to $92.892. Upon request by the SEC staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares and prices at which transactions were effected.